Bliss GVS Pharma Share Price Today - Live Research Rating for Bliss GVS Pharma on Equentis

Home

Stocks Screener

Bliss GVS Pharma Share Price

Bliss GVS Pharma (INR)163.84-4.1 (-2.4%)

Exchange ScripsBSE506197NSEBLISSGVSISININE416D01022

Stock Performance

Fundamentals

Technicals

Shareholding Patterns

Financials

Similar Stocks

Trendline of performance -

Bliss GVS Pharma Performance

Market performance

Open price167.76

High167.8

Volumes1175889

Prev Close163.84

Low161.36

Closing date2024-12-03

Historical performance

1 Year High172.42

3 Year High172.42

5 Year High221.00

1 Year Low92.15

3 Year Low66.10

5 Year Low66.10

Bliss GVS Pharma Fundamentals

Company Valuation

Market Cap (₹Cr)

1730

Face Value (₹)

P/E Ratio

22.73

Dividend Yield

0.31 %

Bliss GVS Pharma Investment Returns

1 Year

16.1%

3 Years

62.3%

5 Years

14.4%

10 Years

128.7%

Bliss GVS Pharma Technicals

Indicators	Value	Signal
5-DMA	159.27	Bullish
10-DMA	144.38	Bullish
20-DMA	133.39	Bullish
50-DMA	130.48	Bullish
100-DMA	125.62	Bullish
200-DMA	119.1	Bullish

Shareholding Pattern

Field	Sep-2024	Jun-2024	Mar-2024	Dec-2023	Sep-2023
Promoters	7	7	7	7	7
Foreign Investors	---	---	---	---	---
Domestic Investors	7	7	7	7	7
Public Investors	52930	44730	45150	40751	43227
Government	---	---	---	---	---

Bliss GVS Pharma Financials

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Other Income	304	178	315	220
Operating Profit	1794	1351	1498	1286
Interest	69	104	47	72
Depreciation	264	187	173	172
Profit Before Tax	1169	1061	542	1041
Consolidated Net Profit	755	709	150	685
Adjusted EPS	7	7	1	7

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	105	104	104	103
Total Reserves	9490	8646	7984	7881
Minority Interest	358	335	278	197
Total Non-Current Liabilities	511	428	292	452
Total Liabilities	12139	11535	11087	10768
Capital Work in Progress	78	28	222	24
Total Assets	12139	11535	11087	10768

Cash Flow

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Cash Flow from Operating Activities	1524	343	1355	640
Cash Flow from Investing Activities	-1328	-78	-930	-470
Cash Flow from Financing Activitie	-209	-249	-237	-208
Net Cash Inflow / Outflow	-13	16	188	-38

Negative

Neutral

Positive

The stock has a PE ratio of 22.73.
3Y Stock Price CAGR of the stock is 17.9.
The stock has a beta of 1.0.
In the last financial year, the company had an EBITDA of ₹1794 Million.
The company generated revenue of ₹7702 Million in the previous financial year.

Bliss GVS Pharma

163.84-4.1 (-2.4%)

Investment Amount: ₹ 14175

Current Value: ₹ 16384

Performence: 15.6%

P/L: ₹ 2209

Top Gainers

Symbol	Change%
JINDWORLD	387.35(20%)
MCL	63.84(20%)
BANG	66.64(20%)
LINCOLN	763.2(20%)
BSL	285.77(19%)

Top Losers

Symbol	Change%
PAR	278.8(-20%)
GRANULES	534.15(-10%)
AKI	16.11(-10%)
MAPMYINDIA	1538.1(-9%)
MALUPAPER	48.24(-9%)
INDGN	626.85(-6%)
STARPAPER	227.82(-6%)
ZENTEC	1806.4(-6%)

Similar stocks

Vimta Labs

▲ 61.3

923.85

November 3 - December 3

Innova Captab

▲ 38.8

1093.4

November 3 - December 3

Krebs Biochem.&Inds

▲ 31.4

106.58

November 3 - December 3

Jagsonpal Pharma

▲ 29.9

714.1

November 3 - December 3

Panacea Biotec

▲ 28.3

446.3

November 3 - December 3

Dishman Carbogen Amc

▲ 27.7

246.72

November 3 - December 3

Supriya Lifescience

▲ 24.8

796.35

November 3 - December 3

Marksans Pharma

▲ 19.8

349.45

November 3 - December 3

Announcing Stock of the Month!

Bliss GVS Pharma Share PricePharmaceuticals & Drugs

Trendline of performance -

Bliss GVS Pharma Performance

Market performance

Historical performance

Bliss GVS Pharma Fundamentals

Company Valuation

Bliss GVS Pharma Investment Returns

Bliss GVS Pharma Technicals

Shareholding Pattern

Bliss GVS Pharma Financials

Balance Sheet

Cash Flow

Top Gainers

Top Losers

Similar stocks

Bliss GVS Pharma Share Price